These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1252 related articles for article (PubMed ID: 26088272)
1. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study. Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272 [TBL] [Abstract][Full Text] [Related]
2. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study. Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799 [TBL] [Abstract][Full Text] [Related]
3. Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. Zhou J; Yu L; Gao X; Hu J; Wang J; Dai Z; Wang JF; Zhang Z; Lu S; Huang X; Wang Z; Qiu S; Wang X; Yang G; Sun H; Tang Z; Wu Y; Zhu H; Fan J J Clin Oncol; 2011 Dec; 29(36):4781-8. PubMed ID: 22105822 [TBL] [Abstract][Full Text] [Related]
4. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma. Zhu HT; Liu RB; Liang YY; Hasan AME; Wang HY; Shao Q; Zhang ZC; Wang J; He CY; Wang F; Shao JY Liver Int; 2017 Jun; 37(6):888-896. PubMed ID: 28061012 [TBL] [Abstract][Full Text] [Related]
5. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. Tomimaru Y; Eguchi H; Nagano H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Tomokuni A; Takemasa I; Umeshita K; Kanto T; Doki Y; Mori M J Hepatol; 2012 Jan; 56(1):167-75. PubMed ID: 21749846 [TBL] [Abstract][Full Text] [Related]
6. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection. Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989 [TBL] [Abstract][Full Text] [Related]
7. Hepatic miR-126 is a potential plasma biomarker for detection of hepatitis B virus infected hepatocellular carcinoma. Ghosh A; Ghosh A; Datta S; Dasgupta D; Das S; Ray S; Gupta S; Datta S; Chowdhury A; Chatterjee R; Mohapatra SK; Banerjee S Int J Cancer; 2016 Jun; 138(11):2732-44. PubMed ID: 26756996 [TBL] [Abstract][Full Text] [Related]
8. microRNA-150: a promising novel biomarker for hepatitis B virus-related hepatocellular carcinoma. Yu F; Lu Z; Chen B; Dong P; Zheng J Diagn Pathol; 2015 Jul; 10():129. PubMed ID: 26215970 [TBL] [Abstract][Full Text] [Related]
9. Profiles of differential expression of circulating microRNAs in hepatitis B virus-positive small hepatocellular carcinoma. Wang Y; Gao Y; Shi W; Zhai D; Rao Q; Jia X; Liu J; Jiao X; Du Z Cancer Biomark; 2015; 15(2):171-80. PubMed ID: 25519019 [TBL] [Abstract][Full Text] [Related]
10. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725 [TBL] [Abstract][Full Text] [Related]
11. The predictive ability of serum alpha-fetoprotein for hepatocellular carcinoma is linked with the characteristics of the target population at surveillance. Huo TI; Hsia CY; Chu CJ; Huang YH; Lui WY; Wu JC; Lee PC; Chi CW; Lee SD J Surg Oncol; 2007 Jun; 95(8):645-51. PubMed ID: 17530668 [TBL] [Abstract][Full Text] [Related]
12. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma. Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961 [TBL] [Abstract][Full Text] [Related]
13. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma. Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881 [TBL] [Abstract][Full Text] [Related]
14. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage. Lin L; Lu B; Yu J; Liu W; Zhou A Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of serum microRNA-574-3p and its clinical significance in hepatocellular carcinoma. Shen X; Xue Y; Cong H; Wang X; Ju S Ann Clin Biochem; 2018 Jul; 55(4):478-484. PubMed ID: 29065698 [TBL] [Abstract][Full Text] [Related]
16. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B. Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223 [TBL] [Abstract][Full Text] [Related]
17. Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Li L; Guo Z; Wang J; Mao Y; Gao Q Dig Dis Sci; 2012 Nov; 57(11):2910-6. PubMed ID: 22865399 [TBL] [Abstract][Full Text] [Related]
18. Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma. Zhuang C; Jiang W; Huang D; Xu L; Yang Q; Zheng L; Wang X; Hu L Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):386-96. PubMed ID: 26669589 [TBL] [Abstract][Full Text] [Related]
19. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma. Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839 [TBL] [Abstract][Full Text] [Related]
20. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Xu J; Wu C; Che X; Wang L; Yu D; Zhang T; Huang L; Li H; Tan W; Wang C; Lin D Mol Carcinog; 2011 Feb; 50(2):136-42. PubMed ID: 21229610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]